This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Feb;14(1):16.

doi: 10.1136/ebm.14.1.16.

CD4+ count-guided antiretroviral therapy interruption increased opportunistic disease and death more than continuous therapy in HIV

Henry S Sacks¹

Affiliations

PMID: 19181948
DOI: 10.1136/ebm.14.1.16

Comment

CD4+ count-guided antiretroviral therapy interruption increased opportunistic disease and death more than continuous therapy in HIV

Henry S Sacks. Evid Based Med. 2009 Feb.

. 2009 Feb;14(1):16.

doi: 10.1136/ebm.14.1.16.

Author

Henry S Sacks¹

Affiliation

¹ Mount Sinai School of Medicine, New York, New York, USA.

PMID: 19181948
DOI: 10.1136/ebm.14.1.16

No abstract available

PubMed Disclaimer

Comment on

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.
Strategies for Management of Antiretroviral Therapy (SMART) Study Group; Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, et al. J Infect Dis. 2008 Apr 15;197(8):1145-55. doi: 10.1086/529523. J Infect Dis. 2008. PMID: 18476293 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program